• Skip to main navigation
  • Skip to main content
  • Skip to Footer
  • Navigate Novartis
    • Patients
    • Healthcare Professionals
    • Media
    • Investors
    • Partners
    • ESG
    • Job Seekers
    • Clinical Trials
  • Coronavirus
  • Global
    • Novartis site directory
Novartis logo: a global healthcare company
  • Our Company
    • Our Leadership
      • Board of Directors
      • Executive Committee of Novartis
    • Our Approach
      • Strategy
      • Corporate Responsibility
      • Diversity & Inclusion
      • Partnering
      • People and Culture
    • Our Business
      • Global Product Portfolio
      • Innovative Medicines
      • Novartis Pharmaceuticals
      • Novartis Gene Therapies
      • Novartis Oncology
      • Sandoz
    • Media
      • Newsroom
      • News Archive
      • Multimedia Resources
      • Subscribe to Updates
    • Investors
      • Event Calendar
      • Financial Data
      • Share Data & Analysis
      • Shareholder Information
      • Environmental, Social & Governance
  • Our Focus
    • Disease Areas
      • Cancer
      • Cardiovascular, Renal and Metabolic Medicine
      • Immunology & Dermatology
      • Ophthalmology
      • Neuroscience
      • Respiratory
    • Platforms and Technology
      • Data and Digital
      • Cell & Gene Therapy
    • Novartis Stories
      • Discovery
      • From Our Labs
      • Access to Healthcare
      • Patient Perspectives
      • People and Culture
      • Live Magazine
  • Our Impact
    • Building Trust with Society
      • Corporate Responsibility
      • Ethical Standards
      • Access
      • Environmental Sustainability
    • Global Health
      • Malaria
      • Sickle Cell Disease
      • Chagas disease
      • Leprosy
      • Novartis Foundation
    • ESG Performance and Reporting
      • Materiality Assessment
      • Environmental, Social and Governance
      • Transparency and Disclosures
      • Positions on Key Topics
      • Statements on Key Issues
  • Our Science
    • Research & Early Development
      • Novartis Institutes for BioMedical Research
      • Research Disease Areas
      • Postdoc Program
      • Open Source Science
    • Drug Development at Novartis
      • Novartis Pipeline
      • Clinical Trials
      • Translational Medicine
      • Global Product Portfolio
    • Science Stories
      • Discovery
      • From Our Labs
  • Careers
    • Your Career
      • Global Career Search
      • Teams and Skills
      • Gene Therapies Careers
    • Working at Novartis
      • Diversity & Inclusion
      • People and Culture
      • Corporate Responsibility
    • Career Programs
      • Our Career Programs
      • Students and Scholars
      • Novartis Quantitative Sciences Hackathon
Search
Cataracts patient, Maria Lucia Martins Moreira
  • TwitterTweet
  • FacebookShare
  • Share
    • Twitter
    • Facebook
    • LinkedIn
    • Email
    • Whatsapp
  • Jump to Comments
Stories/Access to Healthcare

Treating cataracts, a leading cause of preventable blindness worldwide

Cataracts are a serious but common eye condition affecting more than 20 million worldwide. A patient in Brazil tells her story.

By
Brent Stirton
Oct 31, 2014

When Maria Lucia Martins Moreira retired two years ago as a school canteen assistant in the Brazilian city of Sao Paolo, life changed direction, but hardly altered pace. She remained busy caring for her husband and two of her three grandchildren. Then unexpectedly, Maria was dismayed to find her eyesight deteriorating rapidly. After seeking a diagnosis her eye specialist delivered the bad news: she had cataracts.

Cataracts mean Maria has difficulty using public transport, relying on passersby to read bus signs to her.
Cataracts mean Maria has difficulty using public transport, relying on passersby to read bus signs to her. (Photo by Brent Stirton for Novartis)

“It is frightening to lose your ability to see,” said Maria, speaking at her small home in a densely populated area of Sao Paolo. “I lost the sharpness and clarity I’d been used to and then my vision became cloudy. Eventually I could only see the outline of shapes, even with my glasses on. I lost the vision I needed to function normally.”

Cataracts are a serious but common eye condition, most often related to age. They affect more than 20 million people worldwide, according to the World Health Organization. Clumps of proteins in the eye cause a clouding of the normally transparent lens. Although cataracts can be surgically removed, patients in many countries lack access to this treatment and can suffer a severe loss of vision. Cataracts are responsible for more than half of all new cases of blindness around the world, the WHO estimates. As people age, more suffer cataracts and the treatment burden on society will increase.

Cataracts can be surgically removed but patients in many countries lack access to this treatment and can suffer a severe loss of vision. Cataracts are responsible for more than half of all new cases of blindness around the world, according to the World Health Organization.

As Maria found daily activities like reading and cooking impossible without help, the financial implications hit home. Her daughters relied on her to help with child-care so they could hold down their own jobs. And Maria, used to supplementing her own pension with money earned by sewing, began to worry about making ends meet.

Months ago, Maria decided she wanted surgery but she knew it would be costly. Fortunately, she secured a place on the surgical list of a leading Sao Paolo eye surgeon thanks to a community outreach program aimed at widening public access to eye care in the city. Maria headed for the eye surgery clinic, run by university professor Dr. Walton Nosé, with access to a wide range of advanced ophthalmology equipment.

Cataract surgery itself is a relatively standard procedure and patients recover quickly. During the operation, which takes less than 30 minutes under local anesthesia, the surgeon removes the affected lens and replaces it with a small plastic lens called an intraocular implant.

Maria’s hopes for the surgery were simple: to restore enough eyesight for her to live independently again and to be able to look after her grandchildren and enjoy the quality of vision that well-sighted people take for granted.

Her eye surgeries took place on consecutive days. Conscious throughout, Maria said the procedure was straightforward. As a nurse removed the last bandage, she asked to see her grandchildren. And so, armed with eye drops in hand and plastic glasses to protect her eyes from dust and other irritants, Maria went home.

“Few sights are as precious as the faces of your grandchildren,” said Maria, beaming. “Seeing them again clearly was like looking at the faces of angels, a revelation. I am getting back to normal very quickly. I feel blessed.”

World Sight Day is a global initiative celebrated each year to raise awareness and address the global problem of preventable blindness and vision impairment. Novartis eyecare division Alcon partnered with the International Agency for the Prevention of Blindness (IAPB) to drive awareness of the importance of eye health.

Tags: 
Access to Healthcare, Eye Care, Living With Disease

Brent Stirton

Brent Stirton
    • TwitterTweet
    • FacebookShare
    • Share
      • Twitter
      • Facebook
      • LinkedIn
      • Email
      • Whatsapp
    • Jump to Comments
  • Print
  • Save

Novartis Stories

View all

Contains Video
Manufacturing vaccine doses
Access to Healthcare

Novartis joins pharma-wide effort to meet global demand for COVID-19 vaccines

Dr. Theophile Tuyisabe standing next to his patients smiling at him
Access to Healthcare

Meet a visionary who beat the odds to realize his vision of inclusive eye care

Access to Healthcare

Chagas disease: Breaking the silence

You are here

  1. Home ›
  2. Stories ›
  3. Access healthcare

Novartis Global

  • Navigate Novartis

    • Patients & Caregivers
    • Healthcare Professionals
    • Investors
    • Media
    • Society & ESG
    • Partners
  • Contact Us

    • Global Contacts
    • Office Locations
    • For Investors
    • For Media
  • About Novartis

    • Our Company
    • Our Focus
    • Our Impact
    • Our Science
    • Our Stories
  • Our Portfolio

    • Global Product Portfolio
    • Global Clinical Pipeline
  • Careers

    • Career Search

Connect with Novartis

  • twitter
  • linkedin
  • youtube
  • facebook
  • instagram
Novartis Site Directory
© 2021 Novartis AG
  • Terms of Use
  • Privacy Policy
  • Contact Us
  • Site Map
  • Cookie Settings

This site is intended for a global audience.